A randomized study comparing Esomeprazole based versus rabeprazole based triple therapy for the eradication of Helicobacter pylori.

Trial Profile

A randomized study comparing Esomeprazole based versus rabeprazole based triple therapy for the eradication of Helicobacter pylori.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Esomeprazole (Primary) ; Rabeprazole (Primary) ; Amoxicillin; Clarithromycin
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2013 Planned End Date (30 Jun 2013) added as reported by University Hospital Medical Information Network - Japan.
    • 11 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top